% | $
Quotes you view appear here for quick access.

ESSA Pharma Inc. Message Board

  • francolaval francolaval Mar 7, 2003 9:08 AM Flag

    Just listened to their conference.....

    1)No suprise with result i.e. contrast 3D-MRA is known to be better than 2D or 3D MRA.

    2) The first analyst who asked 20 question is dumb. He does not know the market and does not know real life use of contrast-enhanced MR. He thinks MS-325 is the only product that does that! Dumb analyst.
    3) The most important question is CLINICAL UTILITY and at what cost. Gadolinium does exactly the same thing at cheaper prices. Gad will soon be indicated for MRA and hence "legally" used - Epix will face a hard sell in the real world. No one will pay more than Gad. to get the same result. That's the real life.

2.750.00(0.00%)Sep 29 11:07 AMEDT